首页 | 本学科首页   官方微博 | 高级检索  
     

恶性胸腔积液的综合治疗新进展
引用本文:王立伟, 焦顺昌. 恶性胸腔积液的综合治疗新进展[J]. 中国肿瘤临床, 2006, 33(4): 236-239.
作者姓名:王立伟  焦顺昌
作者单位:中国人民解放军总医院肿瘤内科, 北京市 100853
摘    要:恶性胸腔积液(malignantpleuraleffusion,MPE)是晚期恶性肿瘤的常见并发症。MPE治疗的主要目的在于有效地控制胸腔积液,缓解呼吸困难,提高生活质量,延长生存期。本文综述了近年来MPE的多学科多模式的综合治疗现状及研究进展,特别是生物治疗等近年来的研究热点,总结了近年来出现的新药物及新手段。

关 键 词:胸腔积液  肿瘤  治疗
文章编号:1000-8179(2006)04-0234-04
收稿时间:2005-10-21
修稿时间:2005-10-212006-01-19

The Recent Advancement in Comprehensive Treatment of Malignant Pleural Effusions
Wang Li-wei, Jiao Shun-chang. The Recent Advancement in Comprehensive Treatment of Malignant Pleural Effusions[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 33(4): 236-239.
Authors:Wang Liwei  Jiao Shunchang
Affiliation:Department of oncology, the PLA general hospital, Beijing
Abstract:The malignant pleural effusions(MPE)is a common complication in advanced malignancies.The main purpose of MPE therapy lies in effective control of pleural effusions,ease of dyspnea,enhancement of the quality of life and extension of survival time.The article sums up recent comprehensive treatment status and research development of the multidisciplinary modes of MPE,esp.the hot spot such as biotherapy,etc.and summarizes the new drugs and novel means occurred in recent years.
Keywords:Malignancy Pleural effusion Therapy Review
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号